Clinical Trial Update: The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating inhalation of Ventavis with the Power Disc-15 setting for pulmonary hypertension; the trial was terminated and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2012-10-26